News and Trends 20 May 2022 Zealand Pharma’s drug for rare metabolic disease smashes phase III …been diazoxide, which can’t benefit all patients and can cause side effects including nausea and high blood sugar. “As with many other rare diseases, CHI only recently started to get… May 20, 2022 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 10 Nov 2022 SOTIO reveal potential treatment for adults with solid tumors at SITC meeting …cell, BOXR1030, as a potential clinical treatment for the 90% of adult cancer patients with solid tumors. SOTIO: strong clinical path “The GOT2 infused CAR-T cell therapy improved metabolic fitness,… November 10, 2022 - 4 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 21 Dec 2018 French Scientists Find a Weak Spot in HIV-Infected Cells …the French scientists unveiled that HIV prefers to infect those T cells with higher metabolic activity, making them a promising target to get rid of the latent virus. T cells… December 21, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
In Depth 14 May 2018 Could Stem Cells Replace Animal Testing in Drug Development? …an answer to this dilemma as well. There are already iPS cell models available for multiple genetic diseases, including neurological disorders like Parkinson’s as well as blood diseases, cardiac syndromes,… May 14, 2018 - 6 minutesmins - By Timothé Cynober Share WhatsApp Twitter Linkedin Email
News and Trends 31 Jan 2017 New British Biotech-Academia Alliance takes on Cardiovascular Disease Heptares Therapeutics and the University of Cambridge have partnered to investigate a novel target for cardiovascular diseases. Heptares Therapeutics, based in London, develops drugs against historically undruggable G protein-coupled receptors… January 31, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Podcast 19 Apr 2024 The biotech investment landscape in 2024 …disease areas and look across therapeutic areas. So these days we’re very excited about metabolic and obesity and some of the adjacencies like liver diseases,” she explained. Data and disruption:… April 19, 2024 - 8 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 11 Dec 2024 Targeting sugar molecules: Can glycobiology lead to a new era for cancer immunotherapy? …also contribute to immune dysfunction in inflammatory and autoimmune diseases, and targeting sialoglycans and/or their receptors could have therapeutic potential in suppressing the immune system in these diseases. In addition,… December 11, 2024 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 11 Jan 2018 German Biotech Gets FDA Approval to Start an Ulcerative Colitis Phase II Study …II trials for both ulcerative colitis and Crohn’s disease (CD). Dihydroorotatede hydrogenase (DHODH) inhibition causes metabolic stress in active immune cells, leading to their altered function or apoptosis. With diseases… January 11, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
Best in Biotech 16 Jan 2024 Five biotech companies taking Florida by storm …drive the state’s biotech scene. Table of contents AIM ImmunoTech AIM ImmunoTech is focused on researching and developing therapies to treat multiple types of cancers, immune disorders, and viral diseases…. January 16, 2024 - 6 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 30 Sep 2025 CRISPR technology’s next wave: Ten companies to watch in 2025 …technology aims to address various diseases associated with microbiome dysbiosis, including antibiotic-resistant infections and chronic diseases. Unlike broad-spectrum antibiotics, which indiscriminately kill bacteria and disrupt the microbiome, Eligo’s technology selectively… September 30, 2025 - 15 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 1 Mar 2024 The final chapter in genomic medicines? …company be focusing on diseases of the liver. “Fortunately, we were able to scour the landscape of genetic defects of the liver and determine four or five diseases which are… March 1, 2024 - 8 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 20 Jun 2023 NodThera announces positive inflammatory disease data …highly validated drug target that plays a pivotal role in controlling inflammatory diseases. The differentiated design characteristics of each candidate enabled them to penetrate different areas of the brain for… June 20, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email